We observed that the frequency of CD4+Foxp3+ Tregs was significantly increased in the populations of circuiting and tumor-infiltrating T cells from BC patients compared with those from healthy donors, as demonstrated by flow cytometry (Fig. 1a, b, P < 0.05). This evidence concerns the gene FOXP3 and breast cancer.